news.stocktradersdaily3h
(TEVA) Technical Pivots with Risk Controls
Technical analysis for Teva Pharmaceutical Industries Limited American Depositary Shares TEVA including support levels resistance levels and stop losses for TEVA ...
UBS lifts Teva stock price target to $30, maintains Buy rating
UBS analyst Ashwani Verma increased the price target for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) to $30 from the previous $28 while keeping a Buy rating on the shares. Verma highlighted Teva as ...
Pharmaceutical Technology13h
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...
Teva price target raised to $30 from $28 at UBS
UBS raised the firm’s price target on Teva (TEVA) to $30 from $28 and keeps a Buy rating on the shares. Teva, one of the firm’s top picks for ...
Teva Pharmaceuticals: Promising Growth Prospects and Buy Rating Reaffirmed
Bank of America Securities analyst Jason Gerberry has reiterated their bullish stance on TEVA stock, giving a Buy rating on January 21.Invest ...
Diversify Advisory Services LLC Purchases 496 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Diversify Advisory Services LLC raised its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 2.5% during the fourth quarter, according to its most recent ...